Updated September 28, 2018 08:56:25 A genetic mutation has caused a young girl to have an extra copy of a gene known to be associated with the development of breasts.

The mutation is linked to the development in mice of the disease called congenital adrenal hyperplasia, or CAH, in which women develop breast development abnormality.

The gene, called MMP5, was discovered by German scientists in 2007 and is now being used to help treat a number of diseases including breast cancer.

The new finding is important as it could mean that MMP1 and MMP2 genes can be mutated in order to produce new mutations in the body.

The first patients to receive the new treatment, a baby girl named Lola, was born in August this year and is being treated at the Walfheim School of Medicine in Berlin.

“Lola has a mutation in her MMP3 gene that causes a mutation that produces a breast with an extra X chromosome,” said Dr Jürgen Kühn, the research leader at the Max Planck Institute for Developmental Biology in Berlin and the institute’s senior author of the new research.

“If this mutation is removed, she will have a normal breast, but will not have the normal X chromosome in the breast tissue.”

Lola has had a mutation to MMP4, which is linked with a condition known as congenital aplastic anaemia, in the womb.

This causes the body to make too much insulin and then to turn to fat.

This condition is very common in people who have a genetic disorder that leads to fat accumulation in the breasts.

This is the most common type of obesity in people with the disease, and it can cause problems such as breathing problems, poor quality of life and a host of other medical problems.

It is estimated that one in three women worldwide will develop a genetic disease, such as congenial aplasia.

Dr Kühns research team discovered that Lola had the MMP7 gene mutation.

The other mutation is associated with a disease known as FASD, which causes an increased number of tumours in the heart.

This disease is very rare, affecting about one in six people.

However, in people in the highest risk group, which includes women with the mutation, it is about one-in-six.

Dr Sébastien Grosjean, the first author of this research, said: “This study is the first to show that in people of MMP-7 family, a mutation can cause an increase in breast size in addition to the normal reduction of breast tissue in other parts of the body.”

The mutation in Lola’s MMP6 gene was found to have been caused by an enzyme called MCP2B1.

This enzyme is known to make proteins that are involved in the production of prostaglandins, which are chemicals involved in cell growth and growth factors.

This means that the production and function of these proteins can be affected by mutations.

This was confirmed in mice, which were genetically altered to develop the mutation.

These mice are then given a drug that prevents the mutation from occurring.

However the researchers were not able to show any benefit in humans with the new mutation.

However Dr Gros Jénes said the new finding showed that a single mutation in one gene can lead to an increase of breast size.

“It is important to know that it is not an exclusively genetic condition, so that we don’t think that there are too many of these genes, as it can occur in the general population,” he said.

“We are hoping that this discovery will lead to the discovery of many more mutations.”

Researchers hope to find more mutations linked to this new mutation, and eventually, more treatments for breast cancer patients.

This study was published in the journal Nature Genetics.